SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Cell Therapeutics, Inc.' Unique Orally Available, Multi-Kinase (JAK2, FLT3, c-Fms) Inhibitor CT-1578 Demonstrates Ability to Prevent the Onset of Rheumatoid Arthritis and Potency in Treating and Reversing Bone and Cartilage Damage in Preclinical Models